We are live on ! Find out more
BNGO icon

Bionano Genomics
BNGO

143 hedge funds and large institutions have $176M invested in Bionano Genomics in 2022 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 50 increasing their positions, 30 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

132% more call options, than puts

Call options by funds: $4.27M | Put options by funds: $1.84M

67% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 30

21% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 19

20% more capital invested

Capital invested by funds: $146M → $176M (+$29M)

2% more funds holding

Funds holding: 140 → 143 (+3)

0% more ownership

Funds ownership: 0.05% → 0.05% (+0%)

Holders
143
Holders Change
+3
Holders Change %
+2.14%
% of All Funds
2.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
50
Reduced
30
Closed
19
Calls
$4.27M
Puts
$1.84M
Net Calls
+$2.42M
Net Calls Change
-$1.17M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$3.4M
2
Millennium Management
Millennium Management
New York
+$2.39M
3
State Street
State Street
Massachusetts
+$1.98M
4
Citadel Advisors
Citadel Advisors
Florida
+$1.58M
5
Mirae Asset Global Investments
Mirae Asset Global Investments
South Korea
+$814K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$2.58M
2
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management
Japan
-$1.02M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$804K
4
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$749K
5
Two Sigma Investments
Two Sigma Investments
New York
-$694K
Name Holding Trade Value Shares
Change 		Change in
Stake
GI
151
Gradient Investments
Minnesota
$7 – – –
BWL
152
Bogart Wealth LLC
Virginia
$4 – – –
Federated Hermes
153
Federated Hermes
Pennsylvania
$4 – – –
WWP
154
WR Wealth Planners
Missouri
$1 – – –
Renaissance Technologies
155
Renaissance Technologies
New York
– -$2.58M -2,349 Closed
Two Sigma Investments
156
Two Sigma Investments
New York
– -$694K -632 Closed
D.E. Shaw & Co
157
D.E. Shaw & Co
New York
– -$511K -465 Closed
Qube Research & Technologies (QRT)
158
Qube Research & Technologies (QRT)
United Kingdom
– -$267K -244 Closed
Wolverine Trading
159
Wolverine Trading
Illinois
– -$199K -178 Closed
Macquarie Group
160
Macquarie Group
Australia
– -$60K -46 Closed
Amundi
161
Amundi
France
– -$59K -45 Closed
Man Group
162
Man Group
United Kingdom
– -$45K -41 Closed
WTB
163
Washington Trust Bank
Washington
– -$38K -35 Closed
GKWIM
164
Gerber Kawasaki Wealth & Investment Management
California
– -$36K -33 Closed
AWM
165
Apollon Wealth Management
South Carolina
– -$28K -26 Closed
LDFR
166
Lehman & Derafelo Financial Resources
Pennsylvania
– -$26K -23 Closed
CIBC Asset Management
167
CIBC Asset Management
Ontario, Canada
– -$22K -20 Closed
OMC
168
Old Mission Capital
Illinois
– -$21K -19 Closed
RG
169
Retirement Group
California
– -$15K -13 Closed
CWM
170
Castle Wealth Management
Florida
– -$2K -2 Closed
KIG
171
Kessler Investment Group
Indiana
– -$2K -2 Closed
LC
172
Lindbrook Capital
California
– -$1K -1 Closed
3 4 5 6
7

BNGO Hedge Fund Activity: Q4 2022 in Review

143 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q4 2022, worth a combined $176M — up 20% from $146M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new BNGO positions and 19 closed out — a net gain of 4 holders — while 50 added to existing stakes and 30 trimmed.

The largest buyer was BlackRock, adding an estimated $3.4M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $2.58M sold.

  • 143 institutional investors held Bionano Genomics (BNGO) as of Q4 2022, up from 140 in Q3 2022.
  • Funds reported $176M of Bionano Genomics stock for Q4 2022, up 20% quarter-over-quarter.
  • 23 funds opened new Bionano Genomics positions in Q4 2022 and 19 closed out, a net change of +4 holders.
  • The largest Bionano Genomics buyer in Q4 2022 was BlackRock, an estimated $3.4M added.
  • The largest Bionano Genomics seller in Q4 2022 was Renaissance Technologies, an estimated $2.58M sold.

Based on aggregated 13F filings for Q4 2022.